Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IDS PMA accepted

This article was originally published in The Gray Sheet

Executive Summary

Imaging Diagnostic Systems' CTLM computer tomography laser mammography imaging system PMA is deemed suitable for filing by FDA, the firm says June 18. The non-invasive device is intended as an adjunct to mammography to aid in breast cancer detection using 3-D cross-sectional images (1"The Gray Sheet" April 1, 2002, p. 28)...

You may also be interested in...



Laser Mammography PMA To Be Refiled; Dense Breast Imaging Enhanced

Imaging Diagnostic Systems plans to resubmit a premarket approval application for the CTLM computed tomographic laser breast imaging system within the next two months

Imaging Diagnostic Systems Inks Contrast Collaboration With Schering AG

Imaging Diagnostic Systems expects to complete its modular PMA submission for the computer tomography laser mammography (CTLM) imaging system this summer as Schering AG begins a separate feasibility trial of the system with a new contrast agent

Atlas Biomed Unlocking Japan’s OTC Market With Direct-To-Consumer DNA And Microbiome Tests

Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus. 

UsernamePublicRestriction

Register

SC143384

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel